Every patient’s cancer is unique and every patient responds to cancer drugs differently. But right now, all patients with the same kind of cancer are treated with the same drugs.
SEngine Precision Medicine is hoping to change that with new platform, called PARIS, that grows and analyzes a patient’s cancer cells to figure out which drugs will work best for them.
Read the rest right here: https://www.geekwire.com/2018/startup-researchers-get-3-1m-grant-bring-personalized-cancer-fighting-tech-patients/